- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Vivus Inc+ Add to Watchlist
VVUS:US5.3600 USD 0.1100 2.10%
As of 20:10:00 ET on 04/17/2014.
Company Profile for Vivus Inc (VVUS)
VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.
Key Executives for Vivus Inc (VVUS)
|Seth H Z FischerCEO/Chief Commercial Officer||Svai SanfordInterim CFO|
|Lee B PerryVP/Chief Acctg Ofcr/Assistant Secy||John L SlebirSenior VP:Bus Dev/Secy|
|Guy P MarshVP:US Ops/General Manager||Wesley W DayVP:Clinical Development|